Q&A: Common Reasons Independent Pharmacies Face PBM Audits
A conversation with Trent Thiede, PharmD, MBA, president of PAAS National, at NCPA 2024.
Drug Shortages are Impacting Patient Care, Pharmacy Resources
A conversation with Michael Ganio, PharmD, BCPS, FASHP, senior director of Pharmacy Practice and Quality at ASHP.
Community Pharmacists Play Key Role in Diabetes Prevention, Management
Jennifer Goldman, PharmD, CDCES, BC-ADM, FCCP, discusses how pharmacists can help with diabetes prevention and early detection in the community.
How the Inflation Reduction Act Will Impact Pharmacy Reimbursement | ASPL 2024
Pharmacy experts from AON Pharmacy in Florida discussed the Inflation Reduction Act and how it affects reimbursement for Medicare Part D drugs.
Pharmacist-Led CGM Workflow Could Help Improve Diabetes Outcomes
A study found that a continuous glucose monitor workflow led by a pharmacist led to reduced HbA1c levels.
Specialty Pharmacist Transforms HIV Care Outside of the Pharmacy
Cassandra Esperant, PharmD, AAHIVP, discussed the ups and downs of her career journey as a clinical HIV pharmacist.
Q&A: Advantages of NADAC for Stakeholders in the Drug Supply Chain
A conversation with AJ Loiacono, co-founder and CEO of Capital RX, at NCPA 2024.
Black, Hispanic Patients Underrepresented in Food Allergy Immunotherapy Trials
Researchers compared the racial and ethnic representation of participants in food allergen trials with patients who experience food allergies.
The Supreme Court Decisions Impacting Pharmacy Industry, Agency Interactions | ASPL 2024
Selina Coleman, JD, Partner in Life Sciences Health Industry Group at Reed Smith LLP, discussed recent developments in Supreme Court decisions impacting pharmacy operations.
Lenacapavir for PrEP Demonstrates Strong Efficacy, Adherence in Phase 3 Trial
The data from PURPOSE 2 will be published in The New England Journal of Medicine.
FDA Aligns with Pharmacists in Ensuring Integrity of Drug Supply Chain | ASPL 2024
An FDA representative gave a presentation on her organization’s recent updates regarding drug supply chain rules and regulations.
Greater Depression Severity Linked with Increased Diabetes Risk
A recent study found that with greater depression severity, metabolic and clinical characteristics such as HbA1c, fasting blood glucose, and triglyceride levels increased.
How DSCSA Serves as the Drug Supply Chain’s Lead Investigator | ASPL 2024
Pharmacy law experts detailed the Drug Supply Chain Security Act, highlighting the role each entity within the supply chain plays in ensuring the safety and authenticity of US prescription drugs.
Copayment Burden Affects Medication Adherence in Chronic Conditions
High copayments can be a structural barrier to medication therapy adherence.
FDA Accepts BLA Resubmission for Epidermolysis Bullosa Gene Therapy
The agency assigned prademagene zamikeracel a PDUFA target action date of April 29, 2025.
The Nuances of Marijuana’s Potential Rescheduling | ASPL 2024
FDA experts gathered to discuss the DEA’s rescheduling of marijuana and how it will impact the pharmaceutical supply chain.
Q&A: Educating Patients on Importance of Flu Vaccination
Lauren Angelo, PharmD, MBA, discusses effective ways pharmacists can educate and encourage their communities on the importance of flu vaccination.
Overweight, Obesity Linked with Increased Long COVID Risk in Pediatric Patients
Research has found that children and young adults with overweight or obesity may be at a significantly increased risk of developing long COVID.
Prescription Drugs in the US Must Be Viewed as Critical Infrastructure | ASPL 2024
Stephen Schondelmeyer, PharmD, PhD, FAPhA, gave a presentation on US drug shortages and their global implications.
COVID-19 Vaccines May Reduce Incidence of Long COVID Symptoms
A new study found that individuals who received a COVID-19 vaccine more recently were less likely to develop long COVID.
Corresponding Responsibility of Pharmacies, DEA to Uphold Controlled Substances Act | ASPL 2024
Joel Ferre, JD, Assistant United States Attorney in Utah, led a discussion covering the DEA and pharmacies’ roles in reporting red flags when dispensing medication.
FDA Roundup: Rosacea Treatment, Proposal to Remove Oral Phenylephrine from OTC Products
Check out these important FDA updates from the week of November 4.
Gastrointestinal Stromal Tumors Increased in Past 20 Years
Researchers attempted to understand the evolving epidemiology of gastrointestinal stromal tumors in major organ sites.
Q&A: Pharmacists Champion Nonopioid Pain Management Strategies
Melissa Durham, PharmD, MACM, reveals how pharmacists are uniquely positioned to counsel patients on nonopioid pain management.
Q&A: Key Things Pharmacists Need to Know About Insulin Icodec
Jennifer Goldman, PharmD, CDCES, BC-ADM, FCCP, discusses a recent meta-analysis that evaluated the efficacy, safety, and clinical implications of insulin icodec.
Trusting COVID-19 Vaccine Science Crucial in Vaccine Acceptance Among US Adults
A recent study found that losing a family member or a friend to COVID-19 within the past year led to higher levels of vaccine acceptance.
Drug Shortages More Likely in US Than in Canada
Researchers compared the issue of drug shortages and supply chain challenges between the US and Canada.
NCPA 2024 Meeting Recap
Checkout some of the most important sessions and video interviews from the 2024 National Community Pharmacists Association (NCPA) Annual Convention and Expo.
Why Vaccination Uptake is Crucial During the Winter Season
Ruth Carrico, PhD, DNP, APRN, sat down with Drug Topics to discuss the importance of COVID-19 and influenza vaccination.
Insulin Icodec Represents A Promising Option for Managing Diabetes, Improving Quality of Life
Jennifer Goldman, PharmD, CDCES, BC-ADM, FCCP, discusses how insulin icodec differs from existing daily basal insulins and key things pharmacists need to know about the medication.
